FINANCIALS

AMRX Amneal Pharmaceuticals Inc 1723128

Income Statement
Revenue	amrx-20241231	2,793,957,000
Net Income	amrx-20241231	-156,000
Profit Margin		-0.01%

Balance Sheet
Current Assets	1,587,806,000
Assets	3,501,445,000
Current Liabilities	1,129,771,000
Liabilities	3,610,957,000
Equity	-109,512,000
Shares Out	318,999,000

Cash Flow Statement
Operating Cash Flow	295,099,000
Investing Cash Flow	-62,996,000

Market Analysis
Market Cap	4,089,567,082
Price	12.82
BVPS	21.86
PB	0.40
EPS	0.22
PE	57.79
PS	2.78
FCF	232,103,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view AMRX documents filed with the SEC.

AMRX Filings Clear

View A List of Tickers